GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Piramal Pharma Ltd (NSE:PPLPHARMA) » Definitions » Net Interest Income

Piramal Pharma (NSE:PPLPHARMA) Net Interest Income : ₹-4,485 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Piramal Pharma Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. Piramal Pharma's net interest income for the three months ended in Mar. 2024 was ₹-1,142 Mil. Its net interest income for the trailing twelve months (TTM) ended in Mar. 2024 was ₹-4,485 Mil.

Piramal Pharma Net Interest Income Historical Data

The historical data trend for Piramal Pharma's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Piramal Pharma Net Interest Income Chart

Piramal Pharma Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Net Interest Income
159.90 -1,975.70 -3,441.80 -4,484.90

Piramal Pharma Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,042.50 -1,185.20 -1,098.70 -1,058.80 -1,142.20

Piramal Pharma Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-4,485 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Piramal Pharma Net Interest Income Related Terms

Thank you for viewing the detailed overview of Piramal Pharma's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Piramal Pharma (NSE:PPLPHARMA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Piramal Pharma Ltd (NSE:PPLPHARMA) » Definitions » Net Interest Income
Comparable Companies
BOM:533573 BOM:524816 BOM:543064 BOM:506820 BOM:540596 BOM:500126 BOM:540222 BOM:532482 BOM:524742 BOM:543322 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
543635:India
Address
Piramal Ananta, Agastya Corporate Park, Opposite Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai, MH, IND, 400070
Website
https://www.piramal.com
Piramal Pharma Ltd offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries. It includes integrated contract development and manufacturing organization business, complex hospital generics business, and India consumer healthcare business, selling over-the-counter products in India.

Piramal Pharma (NSE:PPLPHARMA) Headlines

No Headlines